tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Rheumatoid Nodule D012218 1 associated lipids
Hernia, Ventral D006555 1 associated lipids
Hepatitis, Autoimmune D019693 1 associated lipids
Moyamoya Disease D009072 1 associated lipids
Polyomavirus Infections D027601 1 associated lipids
Lymphohistiocytosis, Hemophagocytic D051359 1 associated lipids
Multiple Endocrine Neoplasia Type 2a D018813 1 associated lipids
Apraxias D001072 1 associated lipids
Hypertensive Encephalopathy D020343 1 associated lipids
Hearing Loss, Bilateral D006312 1 associated lipids
Nocturia D053158 1 associated lipids
Echinostomiasis D004451 1 associated lipids
Sweet Syndrome D016463 1 associated lipids
Optic Neuritis D009902 1 associated lipids
Granuloma Annulare D016460 1 associated lipids
Paraneoplastic Syndromes, Nervous System D020361 1 associated lipids
Intestinal Fistula D007412 1 associated lipids
Latent Tuberculosis D055985 1 associated lipids
Nephritis, Hereditary D009394 1 associated lipids
Mastocytosis, Cutaneous D034701 1 associated lipids
Pancreatitis, Graft D055589 1 associated lipids
Hearing Loss, Sudden D003639 1 associated lipids
Rectal Diseases D012002 1 associated lipids
Citrullinemia D020159 1 associated lipids
Pulmonary Veno-Occlusive Disease D011668 1 associated lipids
Central Nervous System Viral Diseases D020805 1 associated lipids
Facial Nerve Injuries D020220 1 associated lipids
Intertrigo D007402 1 associated lipids
Miller Fisher Syndrome D019846 1 associated lipids
Cholangitis, Sclerosing D015209 1 associated lipids
Hepatic Insufficiency D048550 1 associated lipids
Lung Abscess D008169 1 associated lipids
Dysplastic Nevus Syndrome D004416 1 associated lipids
Hypoplastic Left Heart Syndrome D018636 1 associated lipids
Mite Infestations D008924 1 associated lipids
Polyendocrinopathies, Autoimmune D016884 1 associated lipids
Leukoplakia D007971 1 associated lipids
Fasciitis, Necrotizing D019115 1 associated lipids
Mediastinal Emphysema D008478 1 associated lipids
Angiolymphoid Hyperplasia with Eosinophilia D000796 1 associated lipids
Eye Infections, Viral D015828 1 associated lipids
Lichen Nitidus D017513 1 associated lipids
Lichenoid Eruptions D017512 1 associated lipids
Lymphocele D008210 1 associated lipids
Colitis, Collagenous D046729 1 associated lipids
Malacoplakia D008287 1 associated lipids
Myoclonic Cerebellar Dyssynergia D002527 1 associated lipids
Eye Diseases, Hereditary D015785 1 associated lipids
Feline Infectious Peritonitis D016766 1 associated lipids
Meningitis, Cryptococcal D016919 1 associated lipids
Oculomotor Nerve Diseases D015840 1 associated lipids
Cutis Laxa D003483 1 associated lipids
Invasive Pulmonary Aspergillosis D055744 1 associated lipids
Intestinal Volvulus D045822 1 associated lipids
Hand Injuries D006230 1 associated lipids
Beckwith-Wiedemann Syndrome D001506 1 associated lipids
IgG Deficiency D017099 1 associated lipids
Deltaretrovirus Infections D006800 1 associated lipids
Hepatopulmonary Syndrome D020065 1 associated lipids
Herpes Labialis D006560 1 associated lipids
End Stage Liver Disease D058625 1 associated lipids
Nocturnal Myoclonus Syndrome D020189 1 associated lipids
Uveomeningoencephalitic Syndrome D014607 1 associated lipids
Myelitis D009187 1 associated lipids
Dendritic Cell Sarcoma, Interdigitating D054739 1 associated lipids
Polymyositis D017285 1 associated lipids
Scorpion Stings D065008 1 associated lipids
Rotavirus Infections D012400 1 associated lipids
Netherton Syndrome D056770 1 associated lipids
Pseudohypoaldosteronism D011546 1 associated lipids
Hepatic Veno-Occlusive Disease D006504 1 associated lipids
West Nile Fever D014901 1 associated lipids
Hypoalbuminemia D034141 1 associated lipids
Arm Injuries D001134 1 associated lipids
Intussusception D007443 1 associated lipids
Thrombotic Microangiopathies D057049 1 associated lipids
Autoimmune Diseases of the Nervous System D020274 1 associated lipids
Lupus Erythematosus, Discoid D008179 1 associated lipids
Lymphocytic Choriomeningitis D008216 1 associated lipids
Erythroplasia D004919 1 associated lipids
Budd-Chiari Syndrome D006502 1 associated lipids
AIDS-Associated Nephropathy D016263 1 associated lipids
Oral Ulcer D019226 1 associated lipids
Epidermolysis Bullosa Dystrophica D016108 1 associated lipids
Primary Graft Dysfunction D055031 1 associated lipids
Esophageal Perforation D004939 1 associated lipids
Epididymitis D004823 1 associated lipids
Pruritus Vulvae D011539 1 associated lipids
Central Serous Chorioretinopathy D056833 1 associated lipids
Feline Acquired Immunodeficiency Syndrome D016181 1 associated lipids
Porokeratosis D017499 1 associated lipids
Lentigo D007911 1 associated lipids
Mutism D009155 1 associated lipids
Amyloid Neuropathies D017772 1 associated lipids
Cervical Intraepithelial Neoplasia D018290 1 associated lipids
Migraine with Aura D020325 1 associated lipids
Flaviviridae Infections D018178 1 associated lipids
Idiopathic Interstitial Pneumonias D054988 1 associated lipids
Dysuria D053159 1 associated lipids
Denys-Drash Syndrome D030321 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Rafecas A et al. Immunosuppression with calcineurin inhibitors and polyclonal antibodies in liver transplantation. 2002 Transplant. Proc. pmid:11959209
Asensio M et al. Experience with tacrolimus as primary immunosuppressor in pediatric liver transplant. 2002 Transplant. Proc. pmid:11959208
Machado PG et al. Use of reduced dose of OKT3 (2.5 mg) after renal transplantation. 2002 Transplant. Proc. pmid:11959207
García-Meseguer C et al. Efficacy and safety of basiliximab in pediatric renal transplantation. 2002 Transplant. Proc. pmid:11959206
Facundo C et al. Results of a triple induction regime with tacrolimus, mycophenolate mofetil, and prednisone in renal transplantation. 2002 Transplant. Proc. pmid:11959203
Herrero JC et al. Role of immunosuppressive treatments based on mycophenolate mofetil in posttransplantation renal surgical complications. 2002 Transplant. Proc. pmid:11959201
Pascual J et al. One-center comparison between primary immunosuppression based on neoral cyclosporine and tacrolimus for renal transplantation. 2002 Transplant. Proc. pmid:11959200
Pascual J and Ortuño J Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy. 2002 Transplant. Proc. pmid:11959198
Urbizu JM et al. Immunosuppression using tacrolimus/mycophenolate versus neoral/mycophenolate following kidney transplantation: a single-center experience. 2002 Transplant. Proc. pmid:11959197
Latorre A et al. Clinical management of renal transplant patients with hepatitis C virus infection treated with cyclosporine or tacrolimus. 2002 Transplant. Proc. pmid:11959186
Norris CM et al. Calcineurin enhances L-type Ca(2+) channel activity in hippocampal neurons: increased effect with age in culture. 2002 Neuroscience pmid:11958864
Macleod MR and Butcher SP Nitric-oxide-synthase-mediated cyclic guanosine monophosphate production in neonatal rat cerebellar prisms is resistant to calcineurin inhibition. 2002 Neurosci. Lett. pmid:11958839
Son IJ et al. Pharmacokinetic changes of intravenous tacrolimus in rats with uranyl nitrate-induced acute renal failure. 2000 Nov-Dec Res. Commun. Mol. Pathol. Pharmacol. pmid:11958289
Trompeter R et al. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. 2002 Pediatr. Nephrol. pmid:11956848
Robichaud GA et al. Nuclear factor of activated T cells is a driving force for preferential productive HIV-1 infection of CD45RO-expressing CD4+ T cells. 2002 J. Biol. Chem. pmid:11956207
Deppe CE et al. Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation. 2002 Endocrinology pmid:11956176
Xie H et al. [Effect of FK506 eye-drop combined with keratoplasty on recurrent Mooren's ulcer]. 2002 Zhonghua Yan Ke Za Zhi pmid:11955293
Schwertfeger E et al. Contractile effects of tacrolimus in human and rat isolated renal arteries. 2001 J Auton Pharmacol pmid:11952876
Turton-Weeks S et al. Pretransplant evaluation of a patient with acute intermittent porphyria. 2001 Prog Transplant pmid:11949465
Li ZY et al. Dimerizer-induced proliferation of genetically modified hepatocytes. 2002 Mol. Ther. pmid:11945069
Chen GF et al. [Peripheral nerve regeneration under immunosuppression]. 2002 Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi pmid:11944523
Passos E et al. Ocular toxicity of intravitreal tacrolimus. 2002 Mar-Apr Ophthalmic Surg Lasers pmid:11942546
Reich K et al. Evidence for a role of Langerhans cell-derived IL-16 in atopic dermatitis. 2002 J. Allergy Clin. Immunol. pmid:11941319
Udina E and Navarro X [Immunophilins: neuroprotective agents and promoters of neural regeneration]. 2002 Neurologia pmid:11940408
Regentin R et al. Production of a novel FK520 analog in Streptomyces hygroscopicus: improving titer while minimizing impurities. 2002 J. Ind. Microbiol. Biotechnol. pmid:11938465
Nör JE et al. Ablation of microvessels in vivo upon dimerization of iCaspase-9. 2002 Gene Ther. pmid:11938459
Goffin E et al. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation. 2002 Transpl. Int. pmid:11935163
Shapiro AM et al. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice. 2002 Diabetologia pmid:11935154
Schwarz NT et al. Protective effects of ex vivo graft radiation and tacrolimus on syngeneic transplanted rat small bowel motility. 2002 Surgery pmid:11935132
Armenti VT et al. National Transplantation Pregnancy Registry looks at outcomes with Neoral and Tacrolimus. 2000 Nephrol News Issues pmid:11933431
Nishino K et al. Suppression of experimental immune-mediated blepharoconjunctivitis in Brown Norway rats by topical application of FK506. 2002 Graefes Arch. Clin. Exp. Ophthalmol. pmid:11931080
Drosos AA Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapy. 2002 Drugs pmid:11929337
Jacobsohn DA and Vogelsang GB Novel pharmacotherapeutic approaches to prevention and treatment of GVHD. 2002 Drugs pmid:11929336
Wellington K and Jarvis B Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis. 2002 Drugs pmid:11929333
Vitulo P et al. Efficacy of tacrolimus rescue therapy in refractory acute rejection after lung transplantation. 2002 J. Heart Lung Transplant. pmid:11927219
Panickar KS et al. Differential response of neural cells to trauma-induced free radical production in vitro. 2002 Neurochem. Res. pmid:11926270
Bolley R et al. Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort. 2002 Transplantation pmid:11923712
Lauzurica R et al. Tacrolimus-associated severe bilateral corneal ulcer after renal transplantation. 2002 Transplantation pmid:11923710
Fuchinoue S et al. Kidney transplantation after liver transplantation from the same donor: four cases of successful steroid withdrawal. 2002 Transplantation pmid:11923698
Bueno OF et al. Calcineurin and hypertrophic heart disease: novel insights and remaining questions. 2002 Cardiovasc. Res. pmid:11922891
Shimomura M et al. Roles of the jejunum and ileum in the first-pass effect as absorptive barriers for orally administered tacrolimus. 2002 J. Surg. Res. pmid:11922737
Oettinger-Barak O et al. Periodontal changes in liver cirrhosis and post-transplantation patients. II: radiographic findings:. 2002 J. Periodontol. pmid:11922262
Tamura S et al. Tacrolimus is a class II low-solubility high-permeability drug: the effect of P-glycoprotein efflux on regional permeability of tacrolimus in rats. 2002 J Pharm Sci pmid:11920757
Ikezumi Y et al. FK506 ameliorates proteinuria and glomerular lesions induced by anti-Thy 1.1 monoclonal antibody 1-22-3. 2002 Kidney Int. pmid:11918741
Segarra A et al. Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up. 2002 Nephrol. Dial. Transplant. pmid:11917061
Sugiura R [Functional analysis of calcineurin-mediated signalling pathway using fission yeast as a model system]. 2002 Nippon Yakurigaku Zasshi pmid:11915517
Gornet JM et al. Severe CPT-11-induced diarrhea in presence of FK-506 following liver transplantation for hepatocellular carcinoma. 2001 Nov-Dec Anticancer Res. pmid:11911319
Trull A et al. Influence of albumin supplementation on tacrolimus and cyclosporine therapy early after liver transplantation. 2002 Liver Transpl. pmid:11910567
Taber DJ et al. Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients. 2002 Liver Transpl. pmid:11910566
Trotter JF et al. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients. 2002 Liver Transpl. pmid:11910565
Macario-Barrel A et al. [Mouth ulcers in patients receiving tacrolimus]. 2001 Ann Dermatol Venereol pmid:11908135
Lacour JP [Topical tacrolimus in dermatology: what can one expect?]. 2001 Ann Dermatol Venereol pmid:11908129
Dé Tran QH et al. Tacrolimus in dermatology. 2001 Jul-Aug J Cutan Med Surg pmid:11907845
Eichenfield LF et al. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. 2002 J. Am. Acad. Dermatol. pmid:11907497
Vincenti F et al. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. 2002 Transplantation pmid:11907427
Klein IH et al. Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. 2002 Transplantation pmid:11907418
Yang H et al. Liposomal encapsulation significantly enchances the immunosuppressive effect of tacrolimus in a discordant islet xenotransplant model. 2002 Transplantation pmid:11907415
Holt S and Moore K Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. 2002 Transplantation pmid:11907407
Sakanoue M et al. Tacrolimus, a specific inhibitor of calcineurin, modifies the locomotor activity of quinpirole, but not that of SKF82958, in male rats. 2002 Eur. J. Pharmacol. pmid:11906716
Ishikawa K et al. Mycobacterium tuberculosis infection of bilateral cervical lymph nodes after renal transplantation. 2001 Int. J. Urol. pmid:11903693
Fuhrer DK et al. Insulin release and suppression by tacrolimus, rapamycin and cyclosporin A are through regulation of the ATP-sensitive potassium channel. 2001 Diabetes Obes Metab pmid:11903410
Bos JD Topical tacrolimus and pimecrolimus are not associated with skin atrophy. 2002 Br. J. Dermatol. pmid:11903264
Vögelin E et al. Long-term viability of articular cartilage after microsurgical whole-joint transplantation and immunosuppression with rapamycin, mycophenolate mofetil, and tacrolimus. 2002 J Hand Surg Am pmid:11901390
Doi M et al. Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine receptor. 2002 Circulation pmid:11901051
Reitamo S et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. 2002 J. Allergy Clin. Immunol. pmid:11898005
Reitamo S et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. 2002 J. Allergy Clin. Immunol. pmid:11898004
Allen BR Tacrolimus ointment: its place in the therapy of atopic dermatitis. 2002 J. Allergy Clin. Immunol. pmid:11897982
Cohen SM Current immunosuppression in liver transplantation. 2002 Mar-Apr Am J Ther pmid:11897926
Tang WX et al. Role of FKBP12.6 in cADPR-induced activation of reconstituted ryanodine receptors from arterial smooth muscle. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:11893565
Beltrani VS Tacrolimus ointment: advancing the treatment of atopic dermatitis. 2001 Curr Allergy Asthma Rep pmid:11892051
Nishigaki F et al. FK506 induces chondrogenic differentiation of clonal mouse embryonic carcinoma cells, ATDC5. 2002 Eur. J. Pharmacol. pmid:11890899
Panz VR et al. Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation1. 2002 Transplantation pmid:11889436
Stempfle HU et al. The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. 2002 Transplantation pmid:11889427
Margreiter R Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study. 2002 Lancet pmid:11888584
del Mar Fernández De Gatta M et al. Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations. 2002 Clin Pharmacokinet pmid:11888332
Präst I et al. Nerve cells in transplanted pancreatic islets: no effects of cyclosporin or tacrolimus on immediate neuronal survival. 2001 Ups. J. Med. Sci. pmid:11888070
Paty BW et al. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. 2002 Transplantation pmid:11884930
Barone GW et al. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation. 2002 JOP pmid:11884766
Merle M Some aspects of hand transplantation. 2001 J Hand Surg Br pmid:11884103
Lanzetta M et al. Hand transplantation: ethics, immunosuppression and indications. 2001 J Hand Surg Br pmid:11884098
McCluskey A et al. Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies. 2002 J. Med. Chem. pmid:11881984
Pascual J [Toward an evidence-based immunosuppression]. 2001 Nefrologia pmid:11881421
Toyonaga T et al. Sudden onset of diabetes with ketoacidosis in a patient treated with FK506/tacrolimus. 2002 Diabetes Res. Clin. Pract. pmid:11879716
Cron RQ HIV-1, NFAT, and cyclosporin: immunosuppression for the immunosuppressed? 2001 DNA Cell Biol. pmid:11879569
Israni A et al. Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant recipients. 2002 Am. J. Kidney Dis. pmid:11877596
Lü L and Zhang W [Immunopathologic studies on the effects of immunosuppressant FK 506 on penetrating keratoplasty rejection model in rat]. 1998 Zhonghua Yan Ke Za Zhi pmid:11877144
Lytton SD et al. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs. 2002 Clin. Exp. Immunol. pmid:11876753
Sarahrudi K et al. The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation. 2002 Transpl. Int. pmid:11875609
Dunn SE et al. Calcineurin and skeletal muscle growth. 2002 Nat. Cell Biol. pmid:11875443
Kosch M et al. Relationship between muscle sympathetic nerve activity and large artery mechanical vessel wall properties in renal transplant patients. 2002 J. Hypertens. pmid:11875318
Choi SH et al. A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection. 2002 Scand. J. Infect. Dis. pmid:11874173
Lawrence MC et al. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1. 2002 Diabetes pmid:11872668
Tanaka K et al. GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum. 2002 Neurosci. Lett. pmid:11872253
Okoshi Y et al. [A case of FK 506-induced leukoencephalopathy]. 2002 No To Shinkei pmid:11868353
Parasrampuria DA et al. Effect of calcineurin inhibitor therapy on P-gp expression and function in lymphocytes of renal transplant patients: a preliminary evaluation. 2002 J Clin Pharmacol pmid:11865967
Kato T et al. Intestinal and multivisceral transplantation. 2002 World J Surg pmid:11865353
Keshavarz R et al. Diabetic ketoacidosis in a child on FK506 immunosuppression after a liver transplant. 2002 Pediatr Emerg Care pmid:11862133
Wu Y and Anderson ME Reduced repolarization reserve in ventricular myocytes from female mice. 2002 Cardiovasc. Res. pmid:11861046
O'Connell PJ et al. Identification of functional type 1 ryanodine receptors in mouse dendritic cells. 2002 FEBS Lett. pmid:11852053
Suehiro A et al. Enhancement by cyclosporine A and tacrolimus of serotonin-induced formation of small platelet aggregation. 2002 Bone Marrow Transplant. pmid:11850703